In this report, we provide evidence that E-cadherin is a novel target of TLE1 in effecting anoikis resistance and its direct transcriptional repression by TLE1 was sufficient to attenuate anoikis sensitivity of lung cancer cells. This evidence concerns the gene TLE1 and lung cancer.